Short-Term Cognitive Behavioral Therapy Effectively Reduced Adolescent Insomnia
Cognitive behavioral therapy (CBT) may reduce the incidence of insomnia symptoms in adolescents, according to study data presented at the 2019 World Sleep Congress.
Treatments
Clinically Important Zoonotic Diseases Part 1: Influenza and Salmonella
The One Health Zoonotic Disease Prioritization workshop, organized jointly by the United States CDC, US Department of Agriculture, and US Department for the Interior, recently reported a list of 8 top zoonotic diseases of national concern.
Family Planning in MS: A Gap in Patient Knowledge
Research highlights the need for healthcare professionals to proactively and directly address the issues and risks of DMTs in terms of MS patients’ family planning activities.
Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease
Fewer individuals in voxelotor group versus placebo group have worsened anemia at week 24.
Efficacy of Lactobacillus reuteri for Acute Gastroenteritis in Children
Among children under age 5 years with acute gastroenteritis, Lactobacillus reuteri DSM 17938 as an adjunct to rehydration therapy did not reduce the duration of diarrhea compared with placebo.
Managing Bisphosphonate Drug Holidays in Patients With Osteoporosis
Ongoing treatment with bisphosphonate therapy may not be needed to prevent future fractures in certain patients due to the sustained effect of the drug.
Patients May Become Immune to Botulinum Toxin Treatments
Findings seen among people with dystonia or spasticity treated with botulinum toxin type A.
Omalizumab Shows Promise as Rescue Therapy in Status Asthmaticus
Omalizumab rescue therapy produced rapid results in a patient with refractory status asthmaticus.
Probiotic Found to Be Effective for Colic in Breastfed Infants
The probiotic Lactobacillus reuteri DSM17938 may be useful for managing colic in breastfed infants; however, its efficacy in formula-fed infants is unclear.
Guidelines on the Use of OnabotulinumtoxinA for Chronic Migraine
Researchers and pain experts formulated guidelines for the use of onabotulinumtoxinA for the management of chronic migraine.
Next post in Pain Information Center
